3war: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
==Crystal structure of human CK2a== | |||
=== | <StructureSection load='3war' size='340' side='right' caption='[[3war]], [[Resolution|resolution]] 1.04Å' scene=''> | ||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[3war]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3WAR OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3WAR FirstGlance]. <br> | |||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=NIO:NICOTINIC+ACID'>NIO</scene></td></tr> | |||
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">CSNK2A1, CK2A1 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens])</td></tr> | |||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] </span></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3war FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3war OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3war RCSB], [http://www.ebi.ac.uk/pdbsum/3war PDBsum]</span></td></tr> | |||
</table> | |||
<div style="background-color:#fffaf0;"> | |||
== Publication Abstract from PubMed == | |||
The Ser/Thr kinase CK2 consists of two catalytic subunits (CK2alpha) and a dimer of the regulatory subunits (CK2beta), and is a ubiquitous enzyme that regulates growth, proliferation and the survival of cells. CK2 is a remarkable drug target for potentially treating a wide variety of tumours and glomerulonephritis. The purified CK2alpha protein was crystallized using ethylene glycol as a precipitant. The crystal structure of CK2alpha with 21 loci of alternative conformations, including a niacin, 19 ethylene glycols and 346 waters, was determined at 1.06 A resolution to an Rwork of 14.0% (Rfree = 16.5%). The alternative ensemble in the internal hydrophobic core underpins the plasticity of the alphaD-helix responsible for the regulation of ATP/GTP binding. The clear density map indicates that a niacin molecule, contained in the Escherichia coli culture medium, binds to the ATP binding site. An ethylene glycol molecule binds in the hydrophobic pocket lateral to the alphaD-helix forming the rim of the active site. The other ethylene glycol molecules occupy physiologically significant sites, including the CK2beta binding interface and substrate binding site, as well as the gap in the crystal packing. Together with water molecules in the active site, these structural insights should facilitate drug discovery. | |||
Crystal structure of human CK2alpha at 1.06 A resolution.,Kinoshita T, Nakaniwa T, Sekiguchi Y, Sogabe Y, Sakurai A, Nakamura S, Nakanishi I J Synchrotron Radiat. 2013 Nov;20(Pt 6):974-9. doi: 10.1107/S0909049513020785., Epub 2013 Oct 2. PMID:24121351<ref>PMID:24121351</ref> | |||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |||
</div> | |||
== | ==See Also== | ||
*[[Casein kinase|Casein kinase]] | |||
== References == | |||
<references/> | |||
__TOC__ | |||
</StructureSection> | |||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Non-specific serine/threonine protein kinase]] | [[Category: Non-specific serine/threonine protein kinase]] | ||
[[Category: Kinoshita, T | [[Category: Kinoshita, T]] | ||
[[Category: Nakamura, S | [[Category: Nakamura, S]] | ||
[[Category: Nakanishi, I | [[Category: Nakanishi, I]] | ||
[[Category: Nakaniwa, T | [[Category: Nakaniwa, T]] | ||
[[Category: Sakurai, A | [[Category: Sakurai, A]] | ||
[[Category: Sekiguchi, Y | [[Category: Sekiguchi, Y]] | ||
[[Category: Sogabe, Y | [[Category: Sogabe, Y]] | ||
[[Category: Protein kinase]] | [[Category: Protein kinase]] | ||
[[Category: Transferase]] | [[Category: Transferase]] |
Revision as of 12:35, 21 December 2014
Crystal structure of human CK2aCrystal structure of human CK2a
Structural highlights
Publication Abstract from PubMedThe Ser/Thr kinase CK2 consists of two catalytic subunits (CK2alpha) and a dimer of the regulatory subunits (CK2beta), and is a ubiquitous enzyme that regulates growth, proliferation and the survival of cells. CK2 is a remarkable drug target for potentially treating a wide variety of tumours and glomerulonephritis. The purified CK2alpha protein was crystallized using ethylene glycol as a precipitant. The crystal structure of CK2alpha with 21 loci of alternative conformations, including a niacin, 19 ethylene glycols and 346 waters, was determined at 1.06 A resolution to an Rwork of 14.0% (Rfree = 16.5%). The alternative ensemble in the internal hydrophobic core underpins the plasticity of the alphaD-helix responsible for the regulation of ATP/GTP binding. The clear density map indicates that a niacin molecule, contained in the Escherichia coli culture medium, binds to the ATP binding site. An ethylene glycol molecule binds in the hydrophobic pocket lateral to the alphaD-helix forming the rim of the active site. The other ethylene glycol molecules occupy physiologically significant sites, including the CK2beta binding interface and substrate binding site, as well as the gap in the crystal packing. Together with water molecules in the active site, these structural insights should facilitate drug discovery. Crystal structure of human CK2alpha at 1.06 A resolution.,Kinoshita T, Nakaniwa T, Sekiguchi Y, Sogabe Y, Sakurai A, Nakamura S, Nakanishi I J Synchrotron Radiat. 2013 Nov;20(Pt 6):974-9. doi: 10.1107/S0909049513020785., Epub 2013 Oct 2. PMID:24121351[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
|